Application of fibroblast growth factor-21 mature peptide in preparation of hepatic fibrosis treatment drugs

The invention discloses application of a fibroblast growth factor-21 mature peptide in preparation of hepatic fibrosis treatment and/or prevention drugs. The invention also discloses a medicine for treating and/or preventing hepatic fibrosis, and the active ingredient of the medicine refers to the f...

Full description

Saved in:
Bibliographic Details
Main Authors REN GUIPING, LI DESHAN, XU PENGFEI
Format Patent
LanguageEnglish
Published 03.02.2016
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention discloses application of a fibroblast growth factor-21 mature peptide in preparation of hepatic fibrosis treatment and/or prevention drugs. The invention also discloses a medicine for treating and/or preventing hepatic fibrosis, and the active ingredient of the medicine refers to the fibroblast growth factor-21 mature peptide. The fibroblast growth factor-21 mature peptide can effectively inhibit hepatic fibrosis, can serve as a medicine for treating and/or preventing hepatic fibrosis and has significant values for treating and/or preventing hepatic fibrosis.
Bibliography:Application Number: CN20151731893